Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered.
The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® product. Essure® was first developed by the company Conceptus in 2001 and was certified for sale throughout Europe, with the first sale occurring in October 2002. In the United States, Essure® was subsequently approved by the FDA on November 4th, 2002. In April 2013, Bayer AG acquired Conceptus to offer Essure® as part of their contraceptive portfolio. In the United Kingdom, the National Institute for Health and Care Excellence approved Essure® in 2009, the last European country to do so. Since Essure® entered the market in 2002, other notable competitors have been the Ovabloc System and the Adiana procedure. Both of these procedures have since been discontinued.
'
TABLE OF CONTENTS I
LIST OF FIGURES III
LIST OF CHARTS V
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
PROCEDURE NUMBERS 11
MARKETS INCLUDED 12
KEY REPORT UPDATES 14
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
1.1 RESEARCH SCOPE 18
1.2 IDATA’S 9-STEP METHODOLOGY 18
1.2.1 Step 1: Project Initiation & Team Selection 18
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 20
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 21
1.2.4 Step 4: Performing Primary Research 22
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 24
1.2.6 Step 6: Market Forecast and Analysis 25
1.2.7 Step 7: Identify Strategic Opportunities 27
1.2.8 Step 8: Final Review and Market Release 28
1.2.9 Step 9: Customer Feedback and Market Monitoring 29
COUNTRY PROFILES 30
2.1 INTRODUCTION 30
2.1.1.1 Population 30
2.1.1.2 Median Age 32
2.1.1.3 GDP Per Capita 32
2.1.1.4 Price Index 33
2.2 GERMANY 34
2.3 FRANCE 35
2.4 UNITED KINGDOM 36
2.5 ITALY 37
2.6 SPAIN 38
2.7 BENELUX 39
2.8 SCANDINAVIA 40
2.9 AUSTRIA 41
2.10 SWITZERLAND 43
2.11 PORTUGAL 44
TRANSCERVICAL FEMALE STERILIZATION MARKET 45
3.1 INTRODUCTION 45
3.1.1 Tubal Ligation 45
3.1.2 Mechanical Sterilization 45
3.1.3 Bipolar Electrocoagulation 46
3.1.4 Transcervical Implant 46
3.2 MARKET ANALYSIS AND FORECAST 47
3.3 DRIVERS AND LIMITERS 55
3.3.1 Market Drivers 55
3.3.2 Market Limiters 56
3.4 COMPETITIVE MARKET SHARE ANALYSIS 59
ABBREVIATIONS 62
Chart 1 1: Gynecological Device Market by Segment, Europe, 2012 – 2022 3
Chart 1 2: Gynecological Device Market Overview, Europe, 2015 & 2022 3
Chart 2 1: Country Profile, Germany, 2015 34
Chart 2 2: Country Profile, France, 2015 35
Chart 2 3: Country Profile, United Kingdom, 2015 36
Chart 2 4: Country Profile, Italy, 2015 37
Chart 2 5: Country Profile, Spain, 2015 38
Chart 2 6: Country Profile, Benelux, 2015 39
Chart 2 7: Country Profile, Scandinavia, 2015 40
Chart 2 8: Country Profile, Austria, 2015 42
Chart 2 9: Country Profile, Switzerland, 2015 43
Chart 2 10: Country Profile, Portugal, 2015 44
Chart 3 1: Transcervical Female Sterilization Market, Europe, 2012 – 2022 49
Chart 3 2: Leading Competitors, Transcervical Female Sterilization Market, Europe, 2015 61
Figure 1 1: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 3) 4
Figure 1 2: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 3) 5
Figure 1 3: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2015 6
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Gynecological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Gynecological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in Gynecological Device Market, Europe, 2012 – 2016 10
Figure 1 9: Gynecological Procedures Covered, Europe, 2015 11
Figure 1 10: Gynecological Device Markets Covered, Europe, 2015 (1 of 2) 12
Figure 1 11: Gynecological Device Markets Covered, Europe, 2015 (2 of 2) 13
Figure 1 12: Key Report Updates (1 of 3) 14
Figure 1 13: Key Report Updates (2 of 3) 15
Figure 1 14: Key Report Updates (3 of 3) 16
Figure 1 15: Version History 17
Figure 2 1: Population by Country, Europe, 2015 30
Figure 2 2: Population, Benelux, 2015 31
Figure 2 3: Scandinavia, Europe, 2015 31
Figure 2 4: GDP per Capita, Europe, 2015 32
Figure 3 1: Transcervical Female Sterilization Market, Europe, 2012 – 2022 (€ and US$) 48
Figure 3 2: Units Sold by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 50
Figure 3 3: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 (€) 51
Figure 3 4: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 (US$) 52
Figure 3 5: Transcervical Female Sterilization Market by Country, Europe, 2012-2022 (€M) 53
Figure 3 6: Transcervical Female Sterilization Market by Country, Europe, 2012-2022 (US$M) 54
Figure 3 7: Drivers and Limiters, Transcervical Female Sterilization Market, Europe, 2015 58
Figure 3 8: Leading Competitors by Country, Transcervical Female Sterilization Market, Europe, 2015 60
Bayer
Karl Storz
Cooper Surgical
Olympus
Richard Wolf
Cook Medical
Johnson & Johnson
Astora Women's Health
Vitrolife
Boston Scientific
Johnson & Johnson
Hologic
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
